The effect of comorbidities on long-term survival in COPD

S. Eroglu (Istanbul, Turkey), H. Yakar (Istanbul, Turkey), E. Yildiz (Istanbul, Turkey), M. Kavas (Istanbul, Turkey), D. Duman (Istanbul, Turkey), H. Günen (Istanbul, Turkey)

Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Session: COPD and extrapulmonary comorbidities
Session type: Thematic Poster
Number: 4028
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Eroglu (Istanbul, Turkey), H. Yakar (Istanbul, Turkey), E. Yildiz (Istanbul, Turkey), M. Kavas (Istanbul, Turkey), D. Duman (Istanbul, Turkey), H. Günen (Istanbul, Turkey). The effect of comorbidities on long-term survival in COPD. 4028

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Gender-dependent predictors for survival in patients with COPD
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019

Paradoxical beneficial effect of obesity in patient centered outcomes and survival in COPD
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009


The natural history of COPD without co-morbidities: predictors of long-term mortality
Source: Annual Congress 2009 - Biomarkers, comorbidities and prognosis of COPD
Year: 2009



The impact on risk-factor analysis of different mortality outcomes in COPD patients
Source: Eur Respir J 2008; 32: 629-636
Year: 2008



No impact of statins on time to first COPD exacerbation or all-cause mortality
Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data
Year: 2021

The effect of changing GOLD severity stage on long-term mortality in COPD
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017

ß2-adrenoceptor modulation in COPD and its potential impact on cardiovascular comorbidities
Source: Eur Respir Monogr 2020; 88: 229-237
Year: 2020


The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013


Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia
Source: Eur Respir J 2014; 43: 36-42
Year: 2004



Prevalence of comorbidity in patients with COPD and its effect on mortality
Source: Annual Congress 2003 - Staging and outcome in COPD
Year: 2003


The impact of depression in recovery and outcome of patients hospitalized for COPD exacerbation
Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care
Year: 2011

Predictors of response of pulmonary rehabilitation (PR) in severe COPD and effect on survival
Source: Annual Congress 2010 - Outcomes and predictors of the sucess of pulmonary rehabilitation in chronic respiratory disease
Year: 2010

Cardiac biomarkers and long-term outcomes of exacerbations of COPD: a long-term follow-up of two cohorts
Source: ERJ Open Res, 7 (1) 00531-2020; 10.1183/23120541.00531-2020
Year: 2021



Role of comorbidities in stable COPD patients mortality
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016


The survival of patients afflicted with COPD and influencing factors
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008

Long-term impact of COPD on postoperative cardiorespiratory morbidity and mortality: a population cohort study
Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases
Year: 2021



Influence of pneumonia on the survival of patients with COPD
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020


Efficiency of therapy of COPD exacerbations and 1-year survival rate after hospitalization
Source: Eur Respir J 2007; 30: Suppl. 51, 556s
Year: 2007

Does improvement in health status affect long term mortality in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 248s
Year: 2002

The impact of decreased 6MWT and exercise-induced desaturation on long-term survival and mortality related to Czech and Spanish phenotypes in patients with severe COPD
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019